Intensity-modulated radiotherapy for cancers in childhood;Radiothérapie conformationnelle par modulation d'intensité des tumeurs pédiatriques

Cancer/Radiotherapie

Volumn 13, Issue 6-7, 2009, Pages 536-542

  Leseur, J ^a,b   Carrie, C ^b   Le Prise E ^a   Bernier, V ^c   Beneyton, V ^b,d   Mahe M A ^e   Supiot, S ^e  

^a CENTRE EUGÈNE MARQUIS   (France)

^b CENTRE LÉON BÉRARD   (France)

^c CENTRE ALEXIS VAUTRIN   (France)

^d CENTRE PAUL STRAUSS   (France)

^e CENTRE RENÉ GAUDUCHEAU   (France)

Author keywords

Doses constraints; IMRT; Indications; Pediatric tumors; Tomotherapy

Indexed keywords

CHILD; CHILDHOOD CANCER; COMPUTER ASSISTED RADIOTHERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LIFE EXPECTANCY; LINEAR ACCELERATOR; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RISK BENEFIT ANALYSIS; SHORT SURVEY; TOMOTHERAPY; TREATMENT INDICATION; ARTICLE; CANCER STAGING; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; MAGNETIC AND ELECTROMAGNETIC EQUIPMENT; MEDULLOBLASTOMA; METHODOLOGY; NEOPLASM; PATHOLOGY; RADIOGRAPHY; RADIOTHERAPY; RHABDOMYOSARCOMA; SCINTISCANNING; TOMOGRAPHY;

CHILD; COGNITION DISORDERS; HUMANS; MEDULLOBLASTOMA; NEOPLASM STAGING; NEOPLASMS; PARTICLE ACCELERATORS; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RHABDOMYOSARCOMA; TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70350703021     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2009.07.006     Document Type: Short Survey

References (54)

1. Al-Sarraf M., LeBlanc M., Giri P.G., Fu K.K., Cooper J., Vuong T., et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 16 (1998) 1310-1317
2. Anon. Guide des procédures de radiothérapie externe 2007. Cancer Radiother 12 (2008) 143-313
3. Anon. Rapport de la Haute autorité de santé. Radiothérapie conformationelle avec modulation d'intensité. Décembre 2006. http://wwwhas-santefr/portail/upload/docs/application/pdf/rapport_rcmi_tomopdf.
4. Bhatnagar A., and Deutsch M. The role for intensity-modulated radiation therapy (IMRT) in pediatric population. Technol Cancer Res Treat 5 (2006) 591-595
5. Bourhis J., Overgaard J., Audry H., Ang K.K., Saunders M., Bernier J., et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 368 (2006) 843-854
6. Breslow N.E., Takashima J.R., Whitton J.A., Moksness J., D'Angio G.J., and Green D.M. Second malignant neoplasms following treatment for Wilm's tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol 13 (1995) 1851-1859
7. Carrie C., Muracciole X., Gomez F., Habrand J.L., Benhassel M., Mege M., et al. Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: results of the French M-SFOP 98 protocol. Int J Radiat Oncol Biol Phys 63 (2005) 711-716
8. Cosset J. Annual meeting of ESTRO 2008 [abstract nr] Suppl. Radiother Oncol. 2008.
9. Curtis A.E., Okcu M.F., Chintagumpala M., Teh B.S., and Paulino A.C. Local control after intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 73 (2009) 173-177
10. Delaney T.F., Liebsch N.J., Pedlow F.X., Adams J., Dean S., Yeap B.Y., et al. Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas. Int J Radiat Oncol Biol Phys 74 3 (2009) 732-739
11. Fogliata A., Nicolini G., Alber M., Asell M., Clivio A., Dobler B., et al. On the performances of different IMRT Treatment Planning Systems for selected paediatric cases. Radiat Oncol 2 (2007) 7
12. Habrand J.L., Abdulkarim B., Beaudre A., el Khouri M., and Kalifa C. La détermination des volumes cibles en radiothérapie pédiatrique : application aux tumeurs cérébrales. Cancer Radiother 5 (2001) 711-719
13. Hall E.J., and Wuu C.S. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 56 (2003) 83-88
14. Hong L., Alektiar K., Chui C., LoSasso T., Hunt M., Spirou S., et al. IMRT of large fields: whole-abdomen irradiation. Int J Radiat Oncol Biol Phys 54 (2002) 278-289
15. Huang E., Teh B.S., Strother D.R., Davis Q.G., Chiu J.K., Lu H.H., et al. Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity. Int J Radiat Oncol Biol Phys 52 (2002) 599-605
16. Jabbour S.K., Zhang Z., Arnold D., and Wharam M.D. Risk of second tumor in intracranial germinoma patients treated with radiation therapy: the Johns Hopkins experience. J Neurooncol 91 (2009) 227-232
17. Jain N., Krull K.R., Brouwers P., Chintagumpala M.M., and Woo S.Y. Neuropsychological outcome following intensity-modulated radiation therapy for pediatric medulloblastoma. Pediatr Blood Cancer 51 (2008) 275-279
18. Kam M.K., Chau R.M., Suen J., Choi P.H., and Teo P.M. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys 56 (2003) 145-157
19. Kantor G., Mahe M.A., Giraud P., Alapetite C., Durdux C., Fourquet A., et al. Évaluation nationale de la tomothérapie hélicoidale : description des indications, des contraintes de dose et des seuils de repositionnement. Cancer Radiother 11 (2007) 331-337
20. Kortmann R.D., Kuhl J., Timmermann B., Mittler U., Urban C., Budach V., et al. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91. Int J Radiat Oncol Biol Phys 46 (2000) 269-279
21. Kozak K.R., Adams J., Krejcarek S.J., Tarbell N.J., and Yock T.I. A dosimetric comparison of proton and intensity-modulated photon radiotherapy for pediatric parameningeal rhabdomyosarcomas. Int J Radiat Oncol Biol Phys 74 (2009) 179-186
22. Kry S.F., Salehpour M., Followill D.S., Stovall M., Kuban D.A., White R.A., et al. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 62 (2005) 1195-1203
23. Kunos C.A., Dobbins D.C., Kulasekere R., Latimer B., and Kinsella T.J. Comparison of helical tomotherapy versus conventional radiation to deliver craniospinal radiation. Technol Cancer Res Treat 7 (2008) 227-233
24. La T.H., Meyers P.A., Wexler L.H., Alektiar K.M., Healey J.H., Laquaglia M.P., et al. Radiation therapy for Ewing's sarcoma: results from Memorial Sloan-Kettering in the modern era. Int J Radiat Oncol Biol Phys 64 (2006) 544-550
25. Lafay-Cousin L., Millar B.A., Mabbott D., Spiegler B., Drake J., Bartels U., et al. Limited-field radiation for bifocal germinoma. Int J Radiat Oncol Biol Phys 65 (2006) 486-492
26. Lee C.T., Bilton S.D., Famiglietti R.M., Riley B.A., Mahajan A., Chang E.L., et al. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?. Int J Radiat Oncol Biol Phys 63 (2005) 362-372
27. Louis C.U., Paulino A.C., Gottschalk S., Bertuch A.A., Chintagumpala M., Heslop H.E., et al. A single institution experience with pediatric nasopharyngeal carcinoma: high incidence of toxicity associated with platinum-based chemotherapy plus IMRT. J Pediatr Hematol Oncol 29 (2007) 500-505
28. Maingon P., Mammar V., Peignaux K., Truc G., and Barillot I. Les contraintes aux organes à risque en radiothérapie par modulation d'intensité des cancers ORL. Cancer Radiother 8 (2004) 234-247
29. Mansur D.B., Klein E.E., and Maserang B.P. Measured peripheral dose in pediatric radiation therapy: a comparison of intensity-modulated and conformal techniques. Radiother Oncol 82 (2007) 179-184
30. Marcy P.Y., Zhu Y., and Bensadoun R.J. Volumes cibles en radiothérapie des tumeurs de la tête et du cou : Radiothérapie conformationelle avec modulation d'intensité (RCMI) des cancers du cavum : aspects pratiques de la délinéation des volumes cibles et des organes critiques. Cancer Radiother 9 (2005) 240-250
31. Marees T., Moll A.C., Imhof S.M., de Boer M.R., Ringens P.J., and van Leeuwen F.E. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up. J Natl Cancer Inst 100 (2008) 1771-1779
32. Merchant T.E., Mulhern R.K., Krasin M.J., Kun L.E., Williams T., Li C., et al. Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma. J Clin Oncol 22 (2004) 3156-3162
33. Mertens R., Granzen B., Lassay L., Gademann G., Hess C.F., and Heimann G. Nasopharyngeal carcinoma in childhood and adolescence: concept and preliminary results of the cooperative GPOH study NPC-91. Gesellschaft fur Padiatrische Onkologie und Hamatologie. Cancer 80 (1997) 951-959
34. e Congrès national de la Societé française de radiothérapie oncologique. Paris 12-14 novembre 2008. Cancer Radiother 12 (2008) 701
35. Michalski J.M., Meza J., Breneman J.C., Wolden S.L., Laurie F., Jodoin M., et al. Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV. Int J Radiat Oncol Biol Phys 59 (2004) 1027-1038
36. Mulhern R.K., Merchant T.E., Gajjar A., Reddick W.E., and Kun L.E. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol 5 (2004) 399-408
37. Mutic S., Low D.A., Klein E.E., Dempsey J.F., and Purdy J.A. Room shielding for intensity-modulated radiation therapy treatment facilities. Int J Radiat Oncol Biol Phys 50 (2001) 239-246
38. Parker W., Filion E., Roberge D., and Freeman C.R. Intensity-modulated radiotherapy for craniospinal irradiation: target volume considerations, dose constraints, and competing risks. Int J Radiat Oncol Biol Phys 69 (2007) 251-257
39. Paulino A.C., Ferenci M.S., Chiang K.Y., Nowlan A.W., and Marcus Jr. R.B. Comparison of conventional to intensity-modulated radiation therapy for abdominal neuroblastoma. Pediatr Blood Cancer 46 (2006) 739-744
40. Penagaricano J.A., Yan Y., Corry P., Moros E., and Ratanatharathorn V. Retrospective evaluation of pediatric cranio-spinal axis irradiation plans with the Hi-ART tomotherapy system. Technol Cancer Res Treat 6 (2007) 355-360
41. Plowman P.N., Cooke K., and Walsh N. Indications for tomotherapy/intensity-modulated radiation therapy in paediatric radiotherapy: extracranial disease. Br J Radiol 81 (2008) 872-880
42. Pollack A., Zagars G.K., Starkschall G., Antolak J.A., Lee J.J., Huang E., et al. Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
43. Raggi E., Mosleh-Shirazi M.A., and Saran F.H. An evaluation of conformal and intensity-modulated radiotherapy in whole ventricular radiotherapy for localised primary intracranial germinomas. Clin Oncol (R Coll Radiol) 20 (2008) 253-260
44. Roberge D., Kun L.E., and Freeman C.R. Intracranial germinoma: on whole-ventricular irradiation. Pediatr Blood Cancer 44 (2005) 358-362
45. Rochet N., Sterzing F., Jensen A., Dinkel J., Herfarth K., Schubert K., et al. Helical tomotherapy as a new treatment technique for whole abdominal irradiation. Strahlenther Onkol 184 (2008) 145-149
46. Schroeder T.M., Chintagumpala M., Okcu M.F., Chiu J.K., Teh B.S., Woo S.Y., et al. Intensity-modulated radiation therapy in childhood ependymoma. Int J Radiat Oncol Biol Phys 71 (2008) 987-993
47. Soomal R., Saran F., and Brada M. In regard to Huang et al.: Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity. IJROBP 52 (2002) 599-605 Int J Radiat Oncol Biol Phys 2003;55:853; author reply -4
48. Supiot S, Munos C, Mahe M, Lisbona A. Whole ventricular irradiation for pediatric intracranial germ cell tumors: A dosimetric study comparing conformal, IMRT and helical IMRT irradiation [Abstract]. Int J Radiat Oncol Biol Phys 2008;72(1): S677-S8.
49. Taylor R.E. Cancer in children: radiotherapeutic approaches. Br Med Bull 52 (1996) 873-886
50. Teh B.S., Mai W.Y., Grant III W.H., Chiu J.K., Lu H.H., Carpenter L.S., et al. Intensity-modulated radiotherapy (IMRT) decreases treatment-related morbidity and potentially enhances tumor control. Cancer Invest 20 (2002) 437-451
51. Trott K. Can we reduce the incidence of second primary malignancies occurring after radiotherapy? [Editorial]. Radiother Oncol 91 (2009) 1-3
52. Tubiana M. Late mortality in Hodgkin's disease: can we reduce it?. Ann Oncol 13 (2002) 5-9
53. Verellen D., and Vanhavere F. Risk assessment of radiation-induced malignancies based on whole-body equivalent dose estimates for IMRT treatment in the head and neck region. Radiother Oncol 53 (1999) 199-203
54. Wolden S.L., Wexler L.H., Kraus D.H., Laquaglia M.P., Lis E., and Meyers P.A. Intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 61 (2005) 1432-1438